D F Nelson|A L Ivanov - JoVE Visualize

Showing results (61-70 of 73) with videos related to

Pageof 8

Sort By:

International Journal of Radiation Oncology, Biology, Physics|March 5, 1998

MR image-guided portal verification for brain treatment fieldF F Yin, Q Gao, H Xie, et al.

Zhurnal Voprosy Neirokhirurgii Imeni N. N. Burdenko|August 31, 2023

[Difficulties in differential diagnosis of sagittal synostosis (scaphocephaly)]L A Satanin, N N Dzhandzhgava, A A Evteev, et al.

International Journal of Radiation Oncology, Biology, Physics|November 1, 1987

Results of a pilot study of hyperfractionated radiation therapy for children with brain stem gliomasR J Packer, P A Littman, R M Sposto, et al.

Cancer Clinical Trials|January 1, 1981

Phase I trials of WR2721 in combination with radiation therapy and with the alkylating agents cyclophosphamide and cis-platinumM M Kligerman, A L Blumberg, J H Glick, et al.

International Journal of Radiation Oncology, Biology, Physics|October 1, 1986

A randomized comparison of misonidazole sensitized radiotherapy plus BCNU and radiotherapy plus BCNU for treatment of malignant glioma after surgery: final report of an RTOG studyD F Nelson, M Diener-West, A S Weinstein, et al.

Cancer|July 15, 1995

Central pathology review in clinical trials for patients with malignant glioma. A Report of Radiation Therapy Oncology Group 83-02C B Scott, J S Nelson, N C Farnan, et al.

Zhurnal Voprosy Neirokhirurgii Imeni N. N. Burdenko|April 4, 2025

[Computer-assisted planning and modeling for the surgical treatment of patients with fibrous dysplasia of cranial vault and base]M M Rakityansky, L A Satanin, A L Ivanov, et al.

International Journal of Radiation Oncology, Biology, Physics|January 15, 1993

Hyperfractionated radiation therapy and bis-chlorethyl nitrosourea in the treatment of malignant glioma--possible advantage observed at 72.0 Gy in 1.2 Gy B.I.D. fractions: report of the Radiation Therapy Oncology Group Protocol 8302D F Nelson, W J Curran, C Scott, et al.

Cancer|April 15, 1996

Final report of a phase I/II trial of hyperfractionated and accelerated hyperfractionated radiation therapy with carmustine for adults with supratentorial malignant gliomas. Radiation Therapy Oncology Group Study 83-02M Werner-Wasik, C B Scott, D F Nelson, et al.

Journal of Neuro-Oncology|March 11, 1992

Does extent of surgery influence outcome for astrocytoma with atypical or anaplastic foci (AAF)? A report from three Radiation Therapy Oncology Group (RTOG) trialsW J Curran, C B Scott, J Horton, et al.

Pageof 8

Showing results (61-70 of 73) with videos related to

Sort By:

Pageof 8

International Journal of Radiation Oncology, Biology, Physics|March 5, 1998

MR image-guided portal verification for brain treatment fieldF F Yin, Q Gao, H Xie, et al.

Zhurnal Voprosy Neirokhirurgii Imeni N. N. Burdenko|August 31, 2023

[Difficulties in differential diagnosis of sagittal synostosis (scaphocephaly)]L A Satanin, N N Dzhandzhgava, A A Evteev, et al.

International Journal of Radiation Oncology, Biology, Physics|November 1, 1987

Results of a pilot study of hyperfractionated radiation therapy for children with brain stem gliomasR J Packer, P A Littman, R M Sposto, et al.

Cancer Clinical Trials|January 1, 1981

Phase I trials of WR2721 in combination with radiation therapy and with the alkylating agents cyclophosphamide and cis-platinumM M Kligerman, A L Blumberg, J H Glick, et al.

International Journal of Radiation Oncology, Biology, Physics|October 1, 1986

A randomized comparison of misonidazole sensitized radiotherapy plus BCNU and radiotherapy plus BCNU for treatment of malignant glioma after surgery: final report of an RTOG studyD F Nelson, M Diener-West, A S Weinstein, et al.

Cancer|July 15, 1995

Central pathology review in clinical trials for patients with malignant glioma. A Report of Radiation Therapy Oncology Group 83-02C B Scott, J S Nelson, N C Farnan, et al.

Zhurnal Voprosy Neirokhirurgii Imeni N. N. Burdenko|April 4, 2025

[Computer-assisted planning and modeling for the surgical treatment of patients with fibrous dysplasia of cranial vault and base]M M Rakityansky, L A Satanin, A L Ivanov, et al.

International Journal of Radiation Oncology, Biology, Physics|January 15, 1993

Hyperfractionated radiation therapy and bis-chlorethyl nitrosourea in the treatment of malignant glioma--possible advantage observed at 72.0 Gy in 1.2 Gy B.I.D. fractions: report of the Radiation Therapy Oncology Group Protocol 8302D F Nelson, W J Curran, C Scott, et al.

Cancer|April 15, 1996

Final report of a phase I/II trial of hyperfractionated and accelerated hyperfractionated radiation therapy with carmustine for adults with supratentorial malignant gliomas. Radiation Therapy Oncology Group Study 83-02M Werner-Wasik, C B Scott, D F Nelson, et al.

Journal of Neuro-Oncology|March 11, 1992

Does extent of surgery influence outcome for astrocytoma with atypical or anaplastic foci (AAF)? A report from three Radiation Therapy Oncology Group (RTOG) trialsW J Curran, C B Scott, J Horton, et al.

Pageof 8